Research programme : anti-Ras antibody therapeutics - Ajou University/Orum Therapeutics

Drug Profile

Research programme : anti-Ras antibody therapeutics - Ajou University/Orum Therapeutics

Alternative Names: RT 11i

Latest Information Update: 23 May 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Ajou University School of Medicine; Orum Therapeutics
  • Developer Ajou University School of Medicine
  • Class Antineoplastics; Monoclonal antibodies
  • Mechanism of Action Ras protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes - Cancer

Highest Development Phases

  • Preclinical Cancer

Most Recent Events

  • 10 May 2017 Research programme : anti-Ras antibody therapeutics - Ajou University/Orum Therapeutics is available for licensing as of 10 May 2017. http://www.orumrx.com/
  • 10 May 2017 Preclinical trials in Cancer in South Korea (Parenteral)
  • 10 May 2017 Pharmacodynamics data from a preclinical trial in Cancer released by Orum Therapeutics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top